US Stock MarketDetailed Quotes

MCRB Seres Therapeutics

Watchlist
  • 9.915
  • +0.185+1.90%
Trading Apr 24 10:58 ET
86.44MMarket Cap495.75P/E (TTM)

Seres Therapeutics Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
Total revenue
0
0
0
0
0
0
0
0
10,300.74%126.47M
-134.96%-522K
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
10,300.74%126.47M
-134.96%-522K
Cost of revenue
3.53M
0
Gross profit
-3.53M
0
Operating expense
-39.63%117.78M
-31.66%25.3M
-34.58%29.17M
-59.27%31.35M
-43.49%39.59M
8.44%195.1M
937.27%37.02M
-28.72%44.59M
19.22%76.95M
22.36%70.05M
Selling and administrative expenses
-31.38%53.18M
-10.86%12.46M
-34.59%12.71M
-42.75%16.06M
-31.17%15.47M
10.30%77.5M
7.77%13.98M
5.70%19.43M
37.94%28.05M
21.00%22.47M
-General and administrative expense
-31.38%53.18M
-10.86%12.46M
-34.59%12.71M
-42.75%16.06M
-31.17%15.47M
10.30%77.5M
7.77%13.98M
5.70%19.43M
37.94%28.05M
21.00%22.47M
Research and development costs
-45.07%64.6M
-44.27%12.84M
-34.56%16.46M
-61.80%17.88M
-50.64%21.7M
7.25%117.6M
235.16%23.04M
-41.66%25.15M
6.50%46.79M
10.90%43.97M
Other operating expenses
----
----
----
-222.93%-2.59M
-32.96%2.42M
----
----
----
677.12%2.11M
469.57%3.61M
Operating profit
37.82%-121.32M
22.12%-28.84M
34.58%-29.17M
-163.29%-31.35M
43.90%-39.59M
-8.44%-195.1M
-2,038.88%-37.02M
24.57%-44.59M
178.21%49.52M
-26.58%-70.57M
Net non-operating interest income expense
-17.92%3.97M
-77.83%437K
-74.65%652K
-51.75%-2.22M
-229.15%-3.02M
263.17%4.83M
522.96%1.97M
398.38%2.57M
-32.10%-1.46M
-73.48%-916K
Non-operating interest income
-45.66%3.97M
-77.83%437K
-74.65%652K
-28.74%1.23M
59.69%1.65M
138.75%7.3M
39.39%1.97M
197.34%2.57M
336.96%1.73M
168.75%1.03M
Non-operating interest expense
--0
--0
--0
8.16%3.45M
139.37%4.66M
-59.00%2.47M
--0
--0
112.33%3.19M
113.60%1.95M
Other net income (expense)
-6,385.82%-8.42M
3,697.92%12.76M
-2,353.95%-22.52M
145.80%692K
696.13%2.47M
119.01%134K
1,560.87%336K
3,127.27%999K
-397.04%-1.51M
189.86%310K
Special income (charges)
--5.68M
----
----
----
----
--0
----
----
----
----
-Gain on sale of business
--5.68M
----
----
----
----
--0
----
----
----
----
Other non- operating income (expenses)
-10,627.61%-14.11M
2,006.25%7.08M
-2,353.95%-22.52M
145.80%692K
696.13%2.47M
119.01%134K
1,560.87%336K
3,127.27%999K
-397.04%-1.51M
189.86%310K
Income before tax
33.85%-125.77M
54.96%-15.64M
-24.43%-51.04M
-170.61%-32.87M
43.61%-40.13M
-3.57%-190.13M
-1,463.83%-34.72M
31.64%-41.02M
171.91%46.55M
-25.70%-71.17M
Income tax
Net income
100.12%136K
62.09%-15.64M
285.51%88.78M
-170.61%-32.87M
43.61%-40.13M
54.54%-113.72M
40.04%-41.25M
20.25%-47.85M
171.91%46.55M
-25.70%-71.17M
Net income continuous Operations
33.85%-125.77M
54.96%-15.64M
-24.43%-51.04M
-170.61%-32.87M
43.61%-40.13M
-3.57%-190.13M
-1,463.83%-34.72M
31.64%-41.02M
171.91%46.55M
-25.70%-71.17M
Net income discontinuous operations
64.79%125.91M
--0
2,144.32%139.81M
----
----
214.77%76.41M
---6.53M
---6.84M
----
----
Minority interest income
Net income attributable to the parent company
100.12%136K
62.09%-15.64M
285.51%88.78M
-170.61%-32.87M
43.61%-40.13M
54.54%-113.72M
40.04%-41.25M
20.25%-47.85M
171.91%46.55M
-25.70%-71.17M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
100.12%136K
62.09%-15.64M
285.51%88.78M
-170.61%-32.87M
43.61%-40.13M
54.54%-113.72M
40.04%-41.25M
20.25%-47.85M
171.91%46.55M
-25.70%-71.17M
Basic earnings per share
0
65.63%-2.2
256.76%11.6
-161.11%-4.4
52.63%-5.4
61.47%-17.8
40.74%-6.4
24.49%-7.4
151.43%7.2
6.56%-11.4
Diluted earnings per share
0
65.63%-2.2
256.76%11.6
-161.11%-4.4
52.63%-5.4
61.47%-17.8
40.74%-6.4
24.49%-7.4
151.43%7.2
6.56%-11.4
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023
Total revenue 0000000010,300.74%126.47M-134.96%-522K
Operating revenue --0--0--0--0--0--0--0--010,300.74%126.47M-134.96%-522K
Cost of revenue 3.53M0
Gross profit -3.53M0
Operating expense -39.63%117.78M-31.66%25.3M-34.58%29.17M-59.27%31.35M-43.49%39.59M8.44%195.1M937.27%37.02M-28.72%44.59M19.22%76.95M22.36%70.05M
Selling and administrative expenses -31.38%53.18M-10.86%12.46M-34.59%12.71M-42.75%16.06M-31.17%15.47M10.30%77.5M7.77%13.98M5.70%19.43M37.94%28.05M21.00%22.47M
-General and administrative expense -31.38%53.18M-10.86%12.46M-34.59%12.71M-42.75%16.06M-31.17%15.47M10.30%77.5M7.77%13.98M5.70%19.43M37.94%28.05M21.00%22.47M
Research and development costs -45.07%64.6M-44.27%12.84M-34.56%16.46M-61.80%17.88M-50.64%21.7M7.25%117.6M235.16%23.04M-41.66%25.15M6.50%46.79M10.90%43.97M
Other operating expenses -------------222.93%-2.59M-32.96%2.42M------------677.12%2.11M469.57%3.61M
Operating profit 37.82%-121.32M22.12%-28.84M34.58%-29.17M-163.29%-31.35M43.90%-39.59M-8.44%-195.1M-2,038.88%-37.02M24.57%-44.59M178.21%49.52M-26.58%-70.57M
Net non-operating interest income expense -17.92%3.97M-77.83%437K-74.65%652K-51.75%-2.22M-229.15%-3.02M263.17%4.83M522.96%1.97M398.38%2.57M-32.10%-1.46M-73.48%-916K
Non-operating interest income -45.66%3.97M-77.83%437K-74.65%652K-28.74%1.23M59.69%1.65M138.75%7.3M39.39%1.97M197.34%2.57M336.96%1.73M168.75%1.03M
Non-operating interest expense --0--0--08.16%3.45M139.37%4.66M-59.00%2.47M--0--0112.33%3.19M113.60%1.95M
Other net income (expense) -6,385.82%-8.42M3,697.92%12.76M-2,353.95%-22.52M145.80%692K696.13%2.47M119.01%134K1,560.87%336K3,127.27%999K-397.04%-1.51M189.86%310K
Special income (charges) --5.68M------------------0----------------
-Gain on sale of business --5.68M------------------0----------------
Other non- operating income (expenses) -10,627.61%-14.11M2,006.25%7.08M-2,353.95%-22.52M145.80%692K696.13%2.47M119.01%134K1,560.87%336K3,127.27%999K-397.04%-1.51M189.86%310K
Income before tax 33.85%-125.77M54.96%-15.64M-24.43%-51.04M-170.61%-32.87M43.61%-40.13M-3.57%-190.13M-1,463.83%-34.72M31.64%-41.02M171.91%46.55M-25.70%-71.17M
Income tax
Net income 100.12%136K62.09%-15.64M285.51%88.78M-170.61%-32.87M43.61%-40.13M54.54%-113.72M40.04%-41.25M20.25%-47.85M171.91%46.55M-25.70%-71.17M
Net income continuous Operations 33.85%-125.77M54.96%-15.64M-24.43%-51.04M-170.61%-32.87M43.61%-40.13M-3.57%-190.13M-1,463.83%-34.72M31.64%-41.02M171.91%46.55M-25.70%-71.17M
Net income discontinuous operations 64.79%125.91M--02,144.32%139.81M--------214.77%76.41M---6.53M---6.84M--------
Minority interest income
Net income attributable to the parent company 100.12%136K62.09%-15.64M285.51%88.78M-170.61%-32.87M43.61%-40.13M54.54%-113.72M40.04%-41.25M20.25%-47.85M171.91%46.55M-25.70%-71.17M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 100.12%136K62.09%-15.64M285.51%88.78M-170.61%-32.87M43.61%-40.13M54.54%-113.72M40.04%-41.25M20.25%-47.85M171.91%46.55M-25.70%-71.17M
Basic earnings per share 065.63%-2.2256.76%11.6-161.11%-4.452.63%-5.461.47%-17.840.74%-6.424.49%-7.4151.43%7.26.56%-11.4
Diluted earnings per share 065.63%-2.2256.76%11.6-161.11%-4.452.63%-5.461.47%-17.840.74%-6.424.49%-7.4151.43%7.26.56%-11.4
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes--------

Market Insights

Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.

Unlock Now

Discussing

FOMC holds rates amid heightened uncertainty: Where will US stocks head next?
🎙️Discussion 1. With the Fed highlighting "elevated uncertainty", are you prioritizing rate projections or near-term economic data for ma Show More